Yale's Dr. Chagpar on Diversity in Clinical Research and Breast Cancer Trials

A very prominent doctor talks about the importance of patient diversity in clinical research trials. Adequate representation from different groups with mixed backgrounds can give researchers a better understanding of the effects that new treatments can have on the general public. Recruiting people with different backgrounds can be challenging but can be achieved by finding ways for sites to relate to these groups.

Guest UserComment